A State-of-the-Art Review of Teach-Back for Patients and Families With Heart Failure: How Far Have We Come?

This was a state-of-the-art narrative review, not a systematic review, and the authors did not formally assess bias or study methods. The included studies were heterogeneous in design, intervention components, teaching dose, and outcome measurement. Teach-back was embedded in multicomponent education, so its independent effect could not be isolated. Most studies did not describe how teach-back was implemented, how clinicians were trained, or how faithfully teach-back was delivered. Many readmission studies lacked a comparison group, and readmission was measured differently across studies. Family care partner involvement was often unclear, including who was assessed and whether they were active learners. The review included only English-language papers, so effects across languages and cultures are not captured. Important outcomes such as patient satisfaction, biomarkers, depression, anxiety, quality of life, medication adherence, symptom burden, mortality, emergency visits, and hospitalizations were under-studied. Demographic information such as race and ethnicity was not consistently reported.

Do not conclude that teach-back alone reduces heart failure readmissions. The reviewed interventions combined teach-back with other education elements, and readmission results were mixed, with several studies not finding reductions.